Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease

Castleman disease (CD) describes a spectrum of heterogeneous disorders defined by characteristic lymph node histopathology. Enlarged lymph nodes demonstrating CD histopathology can occur in isolation (unicentric CD; UCD) sometimes accompanied by mild symptoms, or at multiple sites (multicentric CD, MCD) with systemic inflammation and cytokine-driven multi-organ dysfunction. The discovery that Kaposi sarcoma herpesvirus/human herpesvirus (HHV)-8 drives MCD in a subset of patients has led to the hypotheses that UCD and MCD patients with negative HHV-8 testing by conventional methods may represent false negatives, or that these cases are driven by another virus, known or unknown. To investigate these hypotheses, the virome capture sequencing for vertebrate viruses (VirCapSeq-VERT) platform was employed to detect RNA transcripts from known and novel viruses in fresh frozen lymph node tissue from CD patients (12 UCD, 11 HHV-8-negative MCD [idiopathic MCD; iMCD], and two HHV-8-positive MCD) and related diseases (three T cell lymphoma and three Hodgkin lymphoma). This assay detected HHV-8 in both HHV-8-positive cases; however, HHV-8 was not found in clinically HHV-8-negative iMCD or UCD cases. Additionally, no novel viruses were discovered, and no single known virus was detected with apparent association to HHV-8-negative CD cases. Herpesviridae family members, notably including Epstein-Barr virus (EBV), were detected in 7 out of 12 UCD and 5 of 11 iMCD cases with apparent correlations with markers of disease severity in iMCD. Analysis of a separate cohort of archival formalin-fixed, paraffin-embedded lymph node tissue by In situ hybridization revealed significantly fewer EBV-positive cells in UCD and iMCD compared to tissue from HHV-8-positive MCD and EBV-associated lymphoproliferative disorder. In an additional cohort, quantitative testing for EBV by PCR in peripheral blood during disease flare did not detect systemic EBV viremia, suggesting detection lymph node tissue is due to occult, local reactivation in UCD and iMCD. This study confirms that HHV-8 is not present in UCD and iMCD patients. Further, it fails to establish a clear association between any single virus, novel or known, and CD in HHV-8-negative cases. Given that distinct forms of CD exist with viral and non-viral etiological drivers, CD should be considered a group of distinct and separate diseases with heterogeneous causes worthy of further study.

[1]  J. V. Moran,et al.  Mobile DNA in Health and Disease , 2017, The New England journal of medicine.

[2]  K. Young,et al.  Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. , 2017, Blood.

[3]  J. Rossi,et al.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. , 2017, Blood.

[4]  E. Kirkness,et al.  The blood DNA virome in 8,000 humans , 2017, PLoS pathogens.

[5]  Jennifer K. Sun,et al.  Out of Sight: Culture-Negative Endocarditis and Endophthalmitis. , 2017, The American journal of medicine.

[6]  G. Antonelli,et al.  Torquetenovirus: the human virome from bench to bedside. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  W. Lipkin,et al.  Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis , 2015, mBio.

[8]  W. Lipkin,et al.  A Vision for Investigating the Microbiology of Health and Disease. , 2015, The Journal of infectious diseases.

[9]  Joseph L DeRisi,et al.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.

[10]  F. van Rhee,et al.  HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. , 2014, Blood.

[11]  M. Kojima,et al.  Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012 , 2013, Journal of clinical and experimental hematopathology : JCEH.

[12]  É. Oksenhendler,et al.  Human herpesvirus 8-related Castleman disease in the absence of HIV infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Jie Jin,et al.  High prevalence of hepatitis B virus infection in HIV-negative Castleman's disease , 2012, Annals of Hematology.

[14]  Jack T. Stapleton,et al.  The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae , 2011, The Journal of general virology.

[15]  M. Bower,et al.  Fifty years of multicentric Castleman's disease , 2004, Acta oncologica.

[16]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[17]  P. Murray,et al.  Hodgkin's disease and the Epstein-Barr virus , 2000, Molecular pathology : MP.

[18]  É. Oksenhendler,et al.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. , 2000, Blood.

[19]  Jonathan J. Lewis,et al.  The management of unicentric and multicentric Castleman's disease , 1999, Cancer.

[20]  M. Corbellino,et al.  Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. , 1997, The American journal of pathology.

[21]  V. Calvez,et al.  Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. , 1997, The Journal of infectious diseases.

[22]  C. Boshoff,et al.  Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.

[23]  R. Marasca,et al.  Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease , 1996, Clinical molecular pathology.

[24]  J. Soulier,et al.  Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients , 1996, AIDS.

[25]  L. Young,et al.  Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.

[26]  R. Scully,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. , 1976, The New England journal of medicine.

[27]  B. Castleman,et al.  Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.

[28]  W. Lipkin,et al.  Virus hunting. , 2015, Virology.

[29]  P. Davies,et al.  Journal of Cardiothoracic Surgery BioMed Central , 2009 .

[30]  L. Young,et al.  Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry. , 1995, Hematologic pathology.

[31]  B. Birmingham Epstein-Barr Virus and Hodgkin's Disease: Transcriptional Analysis of Virus Latency in the Malignant Cells By E. M. Deacon, G. Pallesen,* G. Niedobitek,~ J. Crocker, g L. Brooks, A. B. Rickinson, and L. S. Young , 1993 .

[32]  R. Stein,et al.  Multicentric giant lymph node hyperplasia. , 1978, American journal of clinical pathology.